Tackling the reproducibility crisis with standardized human cells

Tuesday, April 29, 2025 at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT

Join experts in human iPSC-derived cells from academia and drug discovery as they discuss the impact of standardization on scientific progress.

The absence of standardized reagents creates barriers to reliable experimental comparisons, slowing research, drug development, and translational efforts. Across human cell models, including primary cells, cell lines, and patient-derived iPSC-derived cells, biological variability and reproducibility challenges persist.

In this expert panel, we will explore how standardizing human iPSC-derived cells can enhance consistency, reproducibility, and regulatory compliance, ultimately enabling more robust and impactful research.

Key learning objectives

• Explore the challenges posed by variability in human cell models
• Understand why a lack of standardized cell models impacts reproducibility, and how implementing it can improve research across academia and industry
• Gain insights on the standardization of human iPSC-derived cells from leaders in academic research and drug discovery

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.